We are live on ! Find out more
MTFB

Motif Bio plc ADRs
MTFB

Delisted

MTFB was delisted on the 16th of December, 2019.

6 hedge funds and large institutions have $455K invested in Motif Bio plc ADRs in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 66 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

52% less capital invested

Capital invested by funds: $950K → $455K (-$495K)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
6
Holders Change
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Invesco
1
Invesco
Georgia
$393K
Renaissance Technologies
2
Renaissance Technologies
New York
$37K -$26.5K -42,505 -29%
VF
3
Virtu Financial
New York
$10K -$502 -806 -3%
Citadel Advisors
4
Citadel Advisors
Florida
$9K +$735 +1,179 +5%
Deutsche Bank
5
Deutsche Bank
Germany
$5K -$47.4K -76,122 -82%
UBS Group
6
UBS Group
Switzerland
$1K +$1.87K +2,994 New
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
-$26K -39,657 Closed

MTFB Hedge Fund Activity: Q3 2019 in Review

6 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc ADRs (MTFB) for Q3 2019, worth a combined $455K — down 52% from $950K a quarter earlier.

Fund positioning in MTFB was balanced in Q3 2019: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 3 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $1.87K. The largest seller was Deutsche Bank, cutting an estimated $47.4K.

  • 6 institutional investors held Motif Bio plc ADRs (MTFB) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $455K of Motif Bio plc ADRs stock for Q3 2019, down 52% quarter-over-quarter.
  • 1 fund opened new Motif Bio plc ADRs positions in Q3 2019 and 1 closed out, a net change of 0 holders.
  • The largest Motif Bio plc ADRs buyer in Q3 2019 was UBS Group, an estimated $1.87K added.
  • The largest Motif Bio plc ADRs seller in Q3 2019 was Deutsche Bank, an estimated $47.4K sold.

Based on aggregated 13F filings for Q3 2019.